Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 11:26 am Sale | 2025-06-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | VANGUARD GROUP INC | 388,875 4.510% | -51,011 (-11.60%) | Filing History |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | BlackRock Inc. BLK | 139,659 1.600% | -504,849 (-78.33%) | Filing History |
| 2025-02-07 4:09 pm Sale | 2024-12-31 | 13G | ATOSSA THERAPEUTICS, INC ATOS | CVI Investments, Inc. | 377,500 4.300% | -140,000 (-27.05%) | Filing History |
| 2024-11-12 1:32 pm Unchanged | 2024-09-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | VANGUARD GROUP INC | 439,886 5.240% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | BlackRock Inc. BLK | 644,508 7.700% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:27 am Purchase | 2024-09-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | VANGUARD GROUP INC | 439,886 5.240% | 60,050 (+15.81%) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | BlackRock Inc. BLK | 644,508 7.700% | 405,262 (+169.39%) | Filing History |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | VANGUARD GROUP INC | 379,836 4.500% | -84,887 (-18.27%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | ATOSSA THERAPEUTICS, INC ATOS | BlackRock Inc. BLK | 239,246 2.800% | -396,727 (-62.38%) | Filing History |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | ATOSSA THERAPEUTICS, INC ATOS | CVI Investments, Inc. | 517,500 5.800% | 264,167 (+104.28%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | ATOSSA THERAPEUTICS, INC ATOS | VANGUARD GROUP INC | 464,723 5.510% | 464,723 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | ATOSSA THERAPEUTICS, INC ATOS | BlackRock Inc. BLK | 635,973 7.500% | 635,973 (New Position) | Filing History |
| 2022-01-13 10:36 am Sale | 2021-12-31 | 13G | ATOSSA THERAPEUTICS, INC ATOS | Empery Asset Management, LP | 87,500 1.030% | -229,867 (-72.43%) | Filing History |